LIFECORE BIOMEDICAL INC
10-C, 1995-11-22
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: DELAWARE GROUP DELCHESTER HIGH YIELD BOND FUND INC, 485BPOS, 1995-11-22
Next: DREYFUS FUND INC, 497, 1995-11-22



<PAGE>
FORM 10-C

Securities and Exchange Commission
Washington, DC 20549

Report by issuer of securities quoted on The Nasdaq Stock Market-Service
Mark-, filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934 and Rule 13a-17 or 15d-17 thereunder.

EXACT NAME OF ISSUER AS SPECIFIED IN CHARTER : LIFECORE BIOMEDICAL, INC.
                                               --------------------------------
ADDRESS OF PRINCIPAL EXECUTIVE OFFICES: 3515 LYMAN BLVD. CHASKA, MN 55318-3051

ISSUERS TELEPHONE NUMBER (INCLUDING AREA CODE): (612)368-4300
                                                -------------------------------

I.  CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate and change (Increase or decrease) of five percent or more in the number
of shares outstanding:

1.  Title of security     Common Stock
                     ----------------------------------------------------------
2.  Number of shares outstanding before the change   7,985,292
                                                  -----------------------------
3.  Number of shares outstanding after the change     10,185,292
                                                  -----------------------------
4.  Effective date of change   October 18, 1995
                             --------------------------------------------------
5.  Method of change       Public Stock Offering
                    -----------------------------------------------------------
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.)
                                                              -----------------
Give brief description of transaction    Public Stock Offering
                                     ------------------------------------------

II  CHANGE IN NAME OF ISSUER

1.  Name prior to change     N/A
                        -------------------------------------------------------
2.  Name after change        N/A
                       --------------------------------------------------------
3.  Effective date of charter amendment changing name     N/A
                                                       ------------------------
4.  Date of shareholder approval of change, if required   N/A
                                                       ------------------------

11/15/95              /s/James W. Bracke,      President & CEO
- -------------------------------------------------------------------------------
DATE:                     OFFICERS SIGNATURE AND TITLE



- -Copyright-June 1974. The Nasdaq Stock Market, Inc.  All rights reserved.
Nasdaq is a registered service mark of The Nasdaq Stock Market, Inc.  The Nasdaq
Stock Market is a service mark of The Nasdaq Stock Market, Inc.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission